Beneficient (NASDAQ:BENF – Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling 75,248 shares, a decrease of 94.8% from the November 30th total of 1,455,762 shares. Currently, 6.7% of the shares of the company are short sold. Based on an average daily trading volume, of 252,897 shares, the short-interest ratio is presently 0.3 days. Based on an average daily trading volume, of 252,897 shares, the short-interest ratio is presently 0.3 days. Currently, 6.7% of the shares of the company are short sold.
Wall Street Analyst Weigh In
A number of brokerages have commented on BENF. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beneficient in a report on Monday. Wall Street Zen upgraded shares of Beneficient to a “sell” rating in a research report on Saturday, November 1st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.
Get Our Latest Stock Analysis on BENF
Beneficient Trading Down 2.8%
About Beneficient
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
See Also
- Five stocks we like better than Beneficient
- Do not delete, read immediately
- A month before the crash
- The boring AI play that could pay up to $4,290 monthly
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Terrifying reason Trump killed the U.S. penny?
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
